Rollins Inc.
ROL
$47.05
-1.51%
Rollins, Inc. is a global leader in route-based pest control services, operating primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia through its flagship Orkin brand and a portfolio of other service brands. The company is a dominant market leader in the US and Canadian pest control industry, distinguished by its extensive national coverage, recurring residential and commercial service contracts, and a strong brand reputation for reliability. The current investor narrative centers on the stock's significant underperformance relative to the market in 2026, driven by concerns over potential margin compression and growth deceleration following its Q4 2025 earnings report, which has sparked a debate about its valuation and near-term growth prospects in a potentially softening economic environment.…
ROL
Rollins Inc.
$47.05
Investment Opinion: Should I buy ROL Today?
Rating: Hold. The core thesis is that Rollins is a high-quality business in the midst of a painful but likely transitional reset, where the significant 26% upside to analyst-implied targets is currently offset by clear and present risks of further margin disappointment and valuation compression. Supporting Evidence: The stock trades at a forward P/E of 33.3x, a premium to the market justified by its 38.3% ROE and $650M TTM free cash flow. Revenue grew 9.7% YoY in Q4, demonstrating the resilience of its model. However, the sharp Q4 operating margin decline to 17.65% and the stock's 31.3% drawdown from its high are severe counterpoints. The implied 26% upside to the ~$58.60 target (33.3x * $1.76 EPS) offers potential reward, but requires confidence in an earnings recovery that recent results have undermined. Risks & Conditions: The two biggest risks are 1) further margin compression invalidating forward earnings estimates, and 2) a sustained derating of its premium multiple. This Hold would upgrade to a Buy if Q4 margins prove anomalous and the next quarter shows operating margin recovering above 19%, or if the forward P/E compresses below 28x while growth remains intact. It would downgrade to a Sell if operating margins fall below 17% or revenue growth decelerates below 7%. Currently, the stock appears fairly valued relative to its near-term uncertainty, but undervalued relative to its long-term quality—a classic Hold scenario.
Sign up to view all
ROL 12-Month Price Forecast
The assessment is neutral with medium confidence. Rollins is caught between its high-quality, cash-generative fundamentals and a deteriorating near-term profitability picture that has shattered investor confidence. The 26% upside to implied targets is compelling, but contingent on a margin recovery that recent data does not support. The base case of a volatile, range-bound recovery is most probable, as the market requires proof that the Q4 miss was an aberration. The stance would upgrade to bullish on evidence of margin stabilization in the next quarter, or turn bearish if the next report shows further compression. For now, the risk/reward is balanced, favoring patience.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rollins Inc.'s 12-month outlook, with a consensus price target around $61.16 and implied upside of +30.0% versus the current price.
Average Target
$61.16
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$38 - $61
Analyst target range
Analyst coverage for Rollins is limited, with only 5 analysts providing estimates, which is relatively sparse for a company of its market cap and suggests it may be under-followed by the broader institutional community. The consensus sentiment, inferred from recent institutional ratings, appears mixed but leans cautiously neutral to slightly bullish, with firms like RBC Capital maintaining 'Outperform' and Morgan Stanley upgrading to 'Overweight' in late 2025, though Wells Fargo downgraded to 'Equal Weight' from 'Overweight' in February 2026. The average revenue estimate for the coming period is $5.46 billion, with a high estimate of $5.57 billion and a low of $5.35 billion, indicating a relatively tight range of expectations around the top line. The target price range is not explicitly provided in the data, but the implied valuation from analyst EPS estimates offers a signal. With an average EPS estimate of $1.76 and applying the current forward PE of 33.3x, it implies a potential price target of approximately $58.60, which would represent a 26% upside from the current price of $46.50. The high EPS estimate of $1.80 implies a target near $60, while the low of $1.71 implies around $57. The wide dispersion in recent analyst actions—from upgrades to downgrades—combined with the significant gap between the current price and implied targets, signals high uncertainty and a lack of consensus on the near-term fundamental trajectory following the disappointing quarterly results.
Bulls vs Bears: ROL Investment Factors
The evidence currently tilts bearish, as the sharp margin compression and valuation premium present more immediate and quantifiable risks than the bullish arguments of cash flow and long-term quality. The most important tension in the investment debate is whether the Q4 margin decline is a temporary, seasonal anomaly or the beginning of a structural profitability reset. If margins stabilize near historical levels, the stock's high-quality fundamentals and oversold condition could drive a significant rebound. However, if margin pressure persists, the lofty forward P/E of 33.3x will contract violently, justifying the recent price collapse. The resolution of this margin trajectory is the single most critical factor for the stock's direction.
Bullish
- Strong Free Cash Flow Generation: Rollins generated $650 million in TTM free cash flow, providing significant financial flexibility for dividends, buybacks, and M&A. This robust cash generation supports the company's 0.62 payout ratio and underpins its defensive business model.
- High Return on Equity: The company boasts an exceptional ROE of 38.3%, indicating highly efficient use of shareholder capital. This level of profitability is a key historical justification for its premium valuation and is a hallmark of its market leadership.
- Analyst Target Implies Significant Upside: Applying the current forward P/E of 33.3x to the average analyst EPS estimate of $1.76 yields an implied price target of ~$58.60, representing a 26% upside from the current price of $46.50. This suggests the recent sell-off may be overdone relative to forward earnings expectations.
- Defensive, Recurring Revenue Model: The pest control business, split between residential ($405M) and commercial ($305M) contracts, provides stable, recurring revenue. This model offers resilience in economic downturns, as evidenced by consistent 9.7% YoY revenue growth in Q4 2025.
Bearish
- Severe Margin Compression in Q4: Q4 2025 operating margin fell to 17.65%, down sharply from 21.93% in Q3 2025. Gross margin also declined to 47.52% from a TTM average of 49.44%, signaling potential inflationary cost pressures or competitive challenges that threaten the core profitability narrative.
- Excessive Valuation Premium: The stock trades at a forward P/E of 33.3x, a significant premium to the market and typical defensive service businesses. This premium is vulnerable to compression if earnings growth fails to meet the implied 65%+ increase baked into the forward multiple.
- Sharp Earnings and Price Deterioration: Q4 2025 EPS of $0.24 declined from $0.34 in Q3, and the stock price has collapsed 31.3% from its 52-week high of $66.14. This simultaneous fundamental and technical breakdown indicates the market is pricing in a material deterioration of the growth story.
- Weak Liquidity Position: A current ratio of 0.60 indicates relatively low liquidity, which could constrain operational flexibility in a downturn. While typical for service businesses, it limits the company's ability to navigate unforeseen financial stress without raising capital.
ROL Technical Analysis
The prevailing price trend for Rollins is a pronounced and sustained downtrend, with the stock down 19.88% over the past year and trading near the bottom of its 52-week range. With a current price of $46.50, it is positioned at just 12.8% of its 52-week range from $44.43 to $66.14, indicating the stock is deeply oversold and probing multi-year lows, which may present a value opportunity but also signals significant negative momentum and bearish sentiment. Recent short-term momentum has been sharply negative, accelerating the longer-term downtrend; the stock is down 14.06% over the past month and 20.21% over the past three months, a stark divergence from the broader market's positive performance as evidenced by a relative strength of -18.66% vs. the S&P 500 over one month. This severe underperformance, culminating in a sharp drop from above $65 in mid-February 2026 to current levels, suggests the market is aggressively pricing in fundamental concerns, likely related to its recent quarterly results. Key technical support is clearly defined at the 52-week low of $44.43, with a break below potentially triggering further algorithmic and psychological selling. Immediate resistance lies at the recent breakdown level near $58-$60, with the major 52-week high of $66.14 representing a distant ceiling. The stock's beta of 0.79 indicates it has been 21% less volatile than the market over the past year, which is unusual given its recent precipitous drop and suggests the sell-off has been driven by idiosyncratic, company-specific news rather than broad market movements, impacting position sizing considerations for risk-averse investors.
Beta
0.73
0.73x market volatility
Max Drawdown
-31.3%
Largest decline past year
52-Week Range
$44-$66
Price range past year
Annual Return
-17.4%
Cumulative gain past year
| Period | ROL Return | S&P 500 |
|---|---|---|
| 1m | -11.2% | -0.1% |
| 3m | -14.7% | +11.4% |
| 6m | -21.6% | +8.2% |
| 1y | -17.4% | +22.7% |
| ytd | -20.3% | +8.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ROL Fundamental Analysis
Rollins' revenue trajectory shows steady growth, with Q4 2025 revenue of $912.9 million representing a 9.7% year-over-year increase. However, analyzing the sequential quarterly trend from the income statements reveals a pattern: revenue peaked at $1.026 billion in Q3 2025 before declining to $912.9 million in Q4, which is a typical seasonal pattern but also indicates growth may be moderating from the higher rates seen in prior quarters. The revenue segment data shows the business is split between Residential Contract Revenue ($405.0 million) and Commercial Contract Revenue ($304.9 million) for the latest period, with both segments essential to its route-based model. The company remains solidly profitable, with Q4 2025 net income of $116.4 million and a net margin of 12.75%. Gross margin for the quarter was 47.52%, which is slightly below the trailing twelve-month gross margin of 49.44% indicated in the valuation data, suggesting some recent pressure. Operating margin for Q4 was 17.65%, down from 21.93% in Q3 2025, indicating potential compression in profitability, a key concern for investors driving the recent sell-off. Rollins exhibits a strong balance sheet and cash flow profile. The company generated $164.7 million in operating cash flow and $159.0 million in free cash flow in Q4 2025, contributing to a robust trailing twelve-month free cash flow of $650.0 million. Its debt-to-equity ratio is a manageable 0.76, indicating a conservative capital structure. However, the current ratio of 0.60 suggests relatively low liquidity, which is typical for service businesses with low inventory but warrants monitoring. The high Return on Equity of 38.3% underscores the company's efficient use of shareholder capital.
Quarterly Revenue
$912913000.0B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.47%
Latest Quarter
Free Cash Flow
$650021000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ROL Overvalued?
Given Rollins' consistent profitability with positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock currently trades at a trailing PE of 55.2x and a forward PE of 33.3x based on estimated EPS. The significant gap between the trailing and forward multiples implies the market expects a substantial recovery in earnings growth, with the forward PE baking in an anticipated 65%+ earnings increase, which aligns with analyst EPS estimates moving from $0.24 in Q4 2025 to a full-year estimate of $1.76. Compared to its sector, Rollins trades at a significant premium. Its forward PE of 33.3x is substantially above the typical market average for stable, defensive service businesses, which often trade in the low-to-mid 20s. This premium is historically justified by the company's high returns on equity, recurring revenue model, and market leadership, but the recent price decline suggests the market is reassessing whether this premium is warranted given the observed margin pressure and growth deceleration. From a historical context, the current trailing PE of 55.2x is near the upper end of its own historical range observed in the provided data, which has fluctuated between approximately 35x and 62x over recent quarters. Trading near the top of its historical band, especially after a sharp price decline, suggests the stock's earnings (the denominator) have contracted faster than its price. This indicates the market is pricing in a deterioration in fundamentals, and the valuation multiple, while high historically, may not yet fully reflect the earnings reset if growth expectations are revised downward further.
PE
55.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 36x~62x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
35.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on profitability sustainability and valuation. The Q4 2025 operating margin compression from 21.93% to 17.65% is a severe warning sign. If this trend continues, the forward P/E of 33.3x, which assumes a sharp earnings recovery, is unsustainable. The company's low current ratio of 0.60, while typical, offers limited buffer against operational hiccups. Revenue, while growing at 9.7% YoY, showed a sequential decline from Q3's $1.026B to Q4's $912.9M, raising questions about growth momentum. Market & Competitive Risks are dominated by valuation compression. Trading at a forward P/E of 33.3x, Rollins carries a massive premium that is historically justified by its high ROE (38.3%) and recurring revenue. However, the recent 31.3% drawdown shows the market is reassessing this premium. A beta of 0.79 indicates the sell-off is idiosyncratic, driven by company-specific news (likely the Q4 report) rather than broad markets, highlighting sensitivity to execution missteps. The stock's defensive nature may offer little protection if the 'quality premium' erodes further. Worst-Case Scenario involves a continuation of margin erosion coupled with a growth slowdown, triggering a full valuation derating. In this scenario, the forward P/E could compress toward the sector average in the low 20s. Applying a 25x multiple to the low-end EPS estimate of $1.71 yields a price of ~$42.75. A break below the key $44.43 support could trigger algorithmic selling, potentially pushing the stock toward the $40 level. From the current $46.50, this represents a realistic downside of 8-14% to the support zone, with a catastrophic scenario risking a 30%+ decline if sentiment turns decisively negative.
FAQ
The key risks are, in order of severity: 1) Profitability Risk: Further operating margin compression from the Q4 level of 17.65%, which would crush forward earnings estimates and derate the P/E multiple. 2) Valuation Risk: The high forward P/E of 33.3x is vulnerable to compression if growth slows, posing significant downside even without an earnings miss. 3) Sentiment & Technical Risk: The stock is in a pronounced downtrend, down 19.9% over the past year, and a break below the $44.43 support could trigger accelerated selling. 4) Liquidity Risk: The low current ratio of 0.60, while common for the industry, offers limited financial flexibility in a downturn.
The 12-month forecast is bifurcated, with a base case target range of $50-$58 (probability 50%), a bull case of $58-$66 (30%), and a bear case of $44-$50 (20%). The most likely scenario (base case) assumes margins stabilize but don't fully recover, leading to EPS near the $1.76 consensus and a modest P/E compression, resulting in a volatile grind higher. The key assumption is that the Q4 2025 margin decline was an anomaly, not a trend. The wide range reflects high uncertainty, but the implied price from analyst EPS estimates and the current forward multiple suggests a ~$58.60 target, or 26% upside from $46.50.
ROL is in a valuation gray area. Its forward P/E of 33.3x is objectively high and represents a significant premium to the broader market, suggesting overvaluation if its growth stumbles. However, this multiple has compressed from even higher levels and now implies a 65%+ earnings growth expectation. Relative to its own historical quality metrics like 38.3% ROE, the stock may be undervalued following a 31.3% drawdown. The market is currently pricing in a deterioration of fundamentals; the stock is fairly valued if margins continue to weaken, but could be undervalued if they recover. The premium multiple is both its greatest risk and potential reward.
ROL presents a high-risk, high-potential-reward opportunity at current levels. For value-oriented investors seeking a quality business at a discount, the 26% implied upside to analyst targets and the stock's oversold condition (trading at 12.8% of its 52-week range) are attractive. However, it is not a good buy for risk-averse investors, as the near-term catalyst is unclear and the stock could retest its $44.43 low if margin pressures persist. It is a good buy only for those with a long-term horizon who believe the company's strong ROE (38.3%) and FCF generation ($650M TTM) will ultimately prevail over near-term operational hiccups.
ROL is suitable primarily for long-term investors with a minimum 2-3 year horizon. The stock's low beta of 0.79 and recurring revenue model support a long-term hold, but the current severe technical downtrend and fundamental uncertainty make it a poor short-term trading vehicle. The investment thesis hinges on the company's durable competitive advantages and high ROE (38.3%) playing out over years, not quarters. Short-term traders face high volatility and unclear catalysts, while long-term investors can potentially benefit from mean reversion in both sentiment and valuation as the company works through its margin challenges.